Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled trial of a simplified four-dose regimen of freeze-dried human rabies vaccine (Vero cell) in healthy participants
CTR20252357Phase 3Active
- Sponsor
- Shandong Yidu Biotechnology
- Start
- Jun 2025
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Freeze-dried Human Rabies Vaccine (Vero cell) in rabies, sponsored by Shandong Yidu Biotechnology. Started Jun 2025; status: active.
02
Drugs
Freeze-dried Human Rabies Vaccine (Vero cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20252357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252357.